News Image

For those who appreciate growth without the sticker shock, NYSE:CI is worth considering.

By Mill Chart

Last update: Apr 8, 2024

Consider THE CIGNA GROUP (NYSE:CI) as an affordable growth stock, identified by our stock screening tool. NYSE:CI is showcasing impressive growth figures and is well-positioned in terms of profitability, solvency, and liquidity. Moreover, it seems to be priced reasonably. Let's dive deeper into the analysis.

Growth Insights: NYSE:CI

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NYSE:CI boasts a 7 out of 10:

  • The Earnings Per Share has grown by an nice 8.05% over the past year.
  • CI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.91% yearly.
  • Looking at the last year, CI shows a quite strong growth in Revenue. The Revenue has grown by 8.42% in the last year.
  • The Revenue has been growing by 32.15% on average over the past years. This is a very strong growth!
  • The Earnings Per Share is expected to grow by 11.43% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 9.51% on average over the next years. This is quite good.

Looking at the Valuation

An integral part of ChartMill's stock analysis is the Valuation Rating, which spans from 0 to 10. This rating evaluates diverse valuation factors, including price to earnings and cash flows, while considering the stock's profitability and growth. NYSE:CI has received a 7 out of 10:

  • CI's Price/Earnings ratio is rather cheap when compared to the industry. CI is cheaper than 89.66% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.07, CI is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio, CI is valued cheaper than 91.38% of the companies in the same industry.
  • CI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.35, which is the current average of the S&P500 Index.
  • Based on the Enterprise Value to EBITDA ratio, CI is valued a bit cheaper than the industry average as 77.59% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CI is valued cheaper than 85.34% of the companies in the same industry.
  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CI has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CI's earnings are expected to grow with 13.35% in the coming years.

Exploring NYSE:CI's Health

ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NYSE:CI, the assigned 5 for health provides valuable insights:

  • CI's Altman-Z score of 2.36 is fine compared to the rest of the industry. CI outperforms 60.34% of its industry peers.
  • CI has a debt to FCF ratio of 3.02. This is a good value and a sign of high solvency as CI would need 3.02 years to pay back of all of its debts.
  • CI has a Debt to FCF ratio of 3.02. This is amongst the best in the industry. CI outperforms 80.17% of its industry peers.

Evaluating Profitability: NYSE:CI

ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NYSE:CI was assigned a score of 6 for profitability:

  • The Return On Assets of CI (3.38%) is better than 73.28% of its industry peers.
  • CI has a Return On Equity of 11.17%. This is in the better half of the industry: CI outperforms 77.59% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.65%, CI is in the better half of the industry, outperforming 77.59% of the companies in the same industry.
  • The 3 year average ROIC (7.18%) for CI is below the current ROIC(7.65%), indicating increased profibility in the last year.
  • The Profit Margin of CI (2.64%) is better than 71.55% of its industry peers.
  • The Operating Margin of CI (4.63%) is better than 63.79% of its industry peers.

Our Affordable Growth screener lists more Affordable Growth stocks and is updated daily.

Our latest full fundamental report of CI contains the most current fundamental analsysis.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

THE CIGNA GROUP

NYSE:CI (4/29/2024, 4:05:00 PM)

After market: 356.44 0 (0%)

356.44

+1.97 (+0.56%)

CI News

News Image9 hours ago - Zacks Investment ResearchWhy Cigna (CI) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

News Image9 hours ago - Zacks Investment ResearchUnveiling Cigna (CI) Q1 Outlook: Wall Street Estimates for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Cigna (CI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.

News Image11 hours ago - ChartmillNYSE:CI stands out as a growth opportunity that won't break the bank.

Don't overlook THE CIGNA GROUP (NYSE:CI)—a stock with solid growth prospects and a reasonable valuation.

News Image3 days ago - The Cigna GroupNew Report: Employers Play Critical Role in Curbing Today's Youth Mental Health Crisis

/PRNewswire/ -- Many American children struggling with mental health challenges do not receive optimal care, and it's exacerbating the damaging ripple effect...

News Image4 days ago - Evernorth Health ServicesEvernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June

/PRNewswire/ -- In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health...

News Image4 days ago - AM BestAM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries
News Image4 days ago - Zacks Investment ResearchCigna (CI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News Image5 days ago - The Cigna GroupThe Cigna Group Declares Quarterly Dividend

/PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.40 per share of its common stock, payable on June 20,...

News Image5 days ago - InvestorPlace3 Healthcare Stocks to Buy Now: Q2 Edition

Between an aging population and increased government spending, investors should consider these three healthcare stocks to buy now.

News Image6 days ago - The Cigna GroupThe Cigna Group Announces Appearance at the BofA Securities 2024 Health Care Conference

/PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, will...

News Image7 days ago - InvestorPlaceThe Top 3 Healthcare Stocks to Buy in April 2024

These are strong buy stocks within the healthcare industry that investors should watch in 2024 due to their strong returns.

News Image7 days ago - BloombergCigna, Humana Merger Deal ‘Math Now Works,’ Jefferies Says

Cigna Group could resume its abandoned pursuit of Humana Inc. after the stock prices have moved to the point where a deal makes financial sense, according to Jefferies.

CI Links
Follow us for more